A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers
Registered Phase 1 interventional trial (withdrawn). The purpose of this study is to determine whether the intravenous administration of single- and multiple-ascending doses of Thymosin Beta 4 is safe and tolerable in healthy volunteers.